VYBRIQUE
Launchsildenafil citrate
NDAORALFILM
Approved
Dec 2025
Lifecycle
Launch
Competitive Pressure
0/100
Clinical Trials
6
Clinical Trials (5)
A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form
Started Jan 2021
0Healthy
Study of Sildenafil Citrate on Insulin Resistance in African American
Started Apr 2011
46 enrolled
Metabolic SyndromeObesity
A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate
Started Jan 2010
47 enrolled
Erectile Dysfunction
Sildenafil Citrate for the Treatment of Established Pre-Eclampsia
Started Sep 2004
76 enrolled
Pre-eclampsia
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
Started Jan 2004
234 enrolled
Pulmonary Arterial Hypertension
Loss of Exclusivity
LOE Date
Dec 16, 2033
94 months away
Patent Expiry
Dec 16, 2033
Exclusivity Expiry
Dec 16, 2028
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 11123287 | Dec 16, 2033 | Product | — |